Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Marker Therapeutics Inc. buy LADENBURG THALM/SH SH

Start price
€4.08
30.04.24 / 50%
Target price
€10.26
30.04.25
Performance (%)
-77.82%
End price
€0.91
01.05.25
Summary
This prediction ended on 01.05.25 with a price of €0.91. The BUY prediction by LADENBURG_THALM_SH_S for Marker Therapeutics Inc. performed very badly with a performance of -77.82%. LADENBURG_THALM_SH_S has a follow-up prediction for Marker Therapeutics Inc. where he still thinks Marker Therapeutics Inc. is a Buy. LADENBURG_THALM_SH_S has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Marker Therapeutics Inc. -5.303% -5.303% -72.345%
iShares Core DAX® 2.850% 3.312% 26.690%
iShares Nasdaq 100 1.612% 5.652% 17.265%
iShares Nikkei 225® 6.401% 11.958% 14.877%
iShares S&P 500 1.346% 4.130% 10.995%

Comments by LADENBURG_THALM_SH_S for this prediction

In the thread Marker Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -77.82%
Target price 10.263
Change
Ends at 30.04.25

Marker Therapeutics, Inc. (NASDAQ: MRKR) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $11.00 price target on the stock.
Ratings data for MRKR provided by MarketBeat

In the thread Trading Marker Therapeutics Inc.
Prediction Buy
Perf. (%) -77.82%
Target price 10.263
Change
Ends at 30.04.25

Die von LADENBURG_THALM_SH_S gewählte maximale Laufzeit wurde überschritten

Current prediction by LADENBURG_THALM_SH_S for Marker Therapeutics Inc.

buy
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.26
21.10.24
€17.56
21.10.25
-75.31%
06.10.25